Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease.
about
Interventions for preventing silent cerebral infarcts in people with sickle cell diseaseInterventions for preventing silent cerebral infarcts in people with sickle cell diseaseNovel insights in the management of sickle cell disease in childhoodHematopoietic stem cell transplantation in sickle cell disease: patient selection and special considerationsNeuroimaging findings in sickle cell diseaseSickle cell anemia: reference values of cerebral blood flow determined by continuous arterial spin labeling MRI.Stroke in patients with sickle cell disease.How I manage cerebral vasculopathy in children with sickle cell disease.Acute silent cerebral infarction in children with sickle cell anemiaHemoglobin and mean platelet volume predicts diffuse T1-MRI white matter volume decrease in sickle cell disease patients.Reproducibility of detecting silent cerebral infarcts in pediatric sickle cell anemia.Discontinuing prophylactic transfusions increases the risk of silent brain infarction in children with sickle cell disease: data from STOP II.Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell diseaseSickle cell disease: an opportunity for palliative care across the life span.Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell diseaseMonocyte protein signatures of disease severity in sickle cell anemia.Pediatric stroke: the importance of cerebral arteriopathy and vascular malformationsSickle cell disease: the neurological complications.Management of sickle cell disease: a review for physician education in Nigeria (sub-saharan Africa).Ischemic stroke in infants and children: practical management in emergency.Managing sickle cell disease.Arterial spin-labeled perfusion combined with segmentation techniques to evaluate cerebral blood flow in white and gray matter of children with sickle cell anemia.Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure.Defining stroke risk in children with sickle cell anaemia.Cerebral hemodynamic assessment and neuroimaging across the lifespan in sickle cell disease.Acute silent cerebral ischemia and infarction during acute anemia in children with and without sickle cell diseaseThe prevention and management of stroke in sickle cell anaemia.Hematopoietic cell transplantation for sickle cell disease: state of the art.Central nervous system complications of sickle cell disease in children: an overview.Neurocognitive sequelae of pediatric sickle cell disease: a review of the literature.Acute silent cerebral ischemic events in children with sickle cell anemia.Current management of sickle cell anemia.Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia.Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.Primary stroke prevention for sickle cell disease in north-east Italy: the role of ethnic issues in establishing a Transcranial Doppler screening programReversible posterior leuko-encephalopathy in children with sickle cell disease.Silent infarcts in young children with sickle cell disease.Genomic polymorphisms in sickle cell disease: implications for clinical diversity and treatment.Current concepts in the management of stroke in children with sickle cell disease.
P2860
Q24186853-BA8C1E6E-36DF-4138-9217-863D2A35FF15Q24200712-A0F7925C-CC7D-46BD-AC43-06DF5A41F7E4Q26767015-47A01937-FC4F-4293-A8F5-845F74644D3AQ26800236-42663334-93C9-4520-A2A1-3178DEE6D693Q26825415-A3137463-4000-439E-A6CE-286A80055A1AQ30365565-A3AA7E8F-AA48-4AEF-BFAF-82E4FA5F4B7CQ30650303-7B790DA4-6B1C-4E93-9C4A-4B566DF615E9Q30945117-A3E269B1-4E42-4BF6-8950-9A23D2535207Q33594605-5002E82B-A8FC-4379-A1D0-F2C78BE6D4C5Q33679897-EA886F20-0A34-4410-90FD-71A704D287E7Q33894066-F6B74D85-F3D5-49C2-AF18-4544057611FFQ33919537-E418ADEB-5D06-41C3-A9BC-8AABC89128D4Q34057698-2905A03D-4207-47BC-90DD-54FAA15608F9Q34100978-AE44CEFF-3034-46BB-8F44-D912AC6B4B1BQ34330904-3D0D0720-0D2F-4CE2-ABE1-AE0ECE9DBA71Q34557931-E92C4E24-085E-44B5-87D5-04C0B7A00F4DQ34660975-1FBEF7B6-1207-4F93-92F5-024956D25D4CQ34703702-447F3939-21A9-4EE2-9CDD-A95948774244Q34733113-27775F7C-0010-4D1E-B7B1-974BC79BCC77Q35034032-5F88BE93-D964-45D9-9721-4CD9E9896743Q35110252-B957B3C6-C15D-48B0-9ED6-101426DECC1CQ35582684-26749BE1-2014-4294-8046-203804152C35Q35781281-5FBDCA02-B755-4793-B18E-4A84373AC949Q35909642-31DBFB98-F232-419C-804A-B781FF18421CQ36065185-56C22583-2CDD-4D72-8B25-11124C06AC0EQ36349336-AF2DDB36-4A66-417D-8A1B-B000AD1A3DE1Q36395580-9D7F70C9-7AC8-43F2-875A-220B9B182404Q36627220-32BD448B-57BC-40CA-943F-E99C746C2A96Q36717337-E28AC17B-0B41-4437-B885-4DFD2B1148EEQ36761420-B086632A-F3B3-4434-8966-8C6DD289F598Q36761424-80BAD727-8BEC-4ED3-A5F7-7E6B5E9775C5Q36914931-EFB3CBD6-6193-4725-AF1D-2D7FB66BDD54Q37040238-A277BCB3-E69C-49BB-A702-7FC9B8D38703Q37178468-DB541366-97C7-404D-99B3-6CA6C3882A40Q37251490-1E63C844-A4A2-425F-8EE8-74DC543A9EA2Q37280183-077C1455-C59C-40A4-A2AF-3AED8B990CCAQ37323730-B56C9DA8-BBD1-4A69-B805-55BDE9277CEEQ37476378-10C88EDE-AFD3-40E9-A61A-0072517C7677Q37810126-9B7F8899-E957-43BB-BC17-0537F3DF2DFBQ37831815-447C6890-FDDE-4011-B980-C46865B3DE7E
P2860
Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Silent infarction as a risk fa ...... Study of Sickle Cell Disease.
@en
Silent infarction as a risk fa ...... Study of Sickle Cell Disease.
@nl
type
label
Silent infarction as a risk fa ...... Study of Sickle Cell Disease.
@en
Silent infarction as a risk fa ...... Study of Sickle Cell Disease.
@nl
prefLabel
Silent infarction as a risk fa ...... Study of Sickle Cell Disease.
@en
Silent infarction as a risk fa ...... Study of Sickle Cell Disease.
@nl
P2093
P356
P1476
Silent infarction as a risk fa ...... Study of Sickle Cell Disease.
@en
P2093
C H Pegelow
Cooperative Study of Sickle Cell Disease
D L Wethers
D M Gallagher
D P Younkin
E P Vichinsky
K Ohene-Frempong
L A Sleeper
P304
P356
10.1067/MPD.2001.117580
P407
P577
2001-09-01T00:00:00Z